JPRN-jRCTs031200281招募中未知
The effect of ivabradine on exercise tolerance in patients with chronic heart failure: a multicenter, open-label, randomized controlled trial - EXCILE-HF trial
Shiga Tsuyoshi0 个研究点目标入组 60 人开始时间: 2021年1月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who are 20 years of age or more with chronic heart failure in New York Heart Association functional classes II and III, a left ventricular ejection fraction lower than 40%, and a resting heart rate of 75 beats per minute or higher in sinus rhythm despite optimal medical therapy for heart failure including beta-blockers.
排除标准
- •Patients with congenital heart disease, severe valvular diseases, active myocarditis, myocardial infarction within the previous 8 weeks, ventricular or atrioventricular pacing >40% of 24 hours, persistent atrial fibrillation or flutter, or symptomatic hypotension.
研究者
相似试验
招募中
2 期
Effect of Ivabradine use on exercise capacity in patients with transposition of the great arteries (TGA) post atrial switch repairCongenital heart diseaseTransposition of great arteriesCardiovascular - Other cardiovascular diseasesACTRN12621000196842Melbourne Health20
招募中
4 期
Effect of Ivabradine in Dilated cardiomyopathy patientsCTRI/2020/03/023767SRM College of Pharmacy
进行中（未招募）
1 期
The Effect of Ivabradine Treatment on Exercise Capacity in Patients with Chronic Rejection after Heart TransplantatioCardiac allograft vasculopathy and elevated resting heart rate in heart transplant recipientsMedDRA version: 20.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849EUCTR2016-004706-33-DKFinn Gustafsson35
Unknown
4 期
Effect of Ivabradine on Exercise Capacity After Heart TransplantationCardiac Allograft VasculopathyTransplanted Heart ComplicationNCT03405831Finn Gustafsson35
已完成
不适用
Investigation of the effect of exercise tolerance decline after lung resection on the prognosislung cancerJPRN-UMIN000035677Matsue Red Cross Hospital99